The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis

Published:2022-12 Issue: Volume:135 Page:106231
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Xue Song^ORCID,Song Ge,Zhu Yingming,Zhang Nianping,Tan Ying

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference39 articles.

1. Nasopharyngeal carcinoma;Chua;Lancet,2016

2. VEGF targets the tumour cell;Goel;Nat Rev Cancer,2013

3. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival;Hui;Clin Cancer Res,2002

4. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma;Qian;Cancer,2000

5. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status;Krishna;Virus Res,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma;Oral Oncology;2023-10

2. Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma;Anticancer Research;2023-09-29

3. Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models;Investigational New Drugs;2023-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP